Related Experiment Video
Updated: Feb 6, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Personalized cancer neoantigen vaccines come of age
Yanhong Chu1, Qin Liu1, Jia Wei1
1The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, China.
Abstract:
Cancer vaccines have encountered their ideal personalized partner along with evidence for great breakthroughs in the identification and synthesis of neoantigens. Individual cancer neoantigen vaccines are capable of eliciting robust T-cell responses and have been demonstrated to achieve striking clinical efficacy due to their high immunogenicity and central thymic tolerance escape of neoantigens. Two recent phase I clinical trials have provided support for the hypothesis and have heralded a nascent era of personalized vaccines in the field of immunotherapy. This review aims to address the identification of neoepitopes and describes advances made in personalized vaccines. In addition, this review discusses the challenges related to the exploitation of vaccine therapy, and provides potential thoughts for the improvement of vaccine design and applications.
Insights
Personalized cancer neoantigen vaccines show promise, eliciting strong T-cell responses and demonstrating clinical efficacy. Advances in neoantigen identification and personalized vaccine design herald a new era in cancer immunotherapy.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Neoantigens are key targets for personalized cancer vaccines.
- Neoantigen vaccines can stimulate robust T-cell responses.
- Clinical trials show promising efficacy for personalized cancer vaccines.
Purpose of the Study:
- To review advances in neoantigen identification and personalized vaccine development.
- To discuss challenges and future directions in cancer vaccine therapy.
Main Methods:
- Review of recent clinical trials and scientific literature.
- Analysis of neoantigen identification and synthesis strategies.
- Discussion of immunotherapy principles and vaccine design.
Main Results:
- Personalized neoantigen vaccines demonstrate high immunogenicity.
- Neoantigen vaccines can escape central thymic tolerance.
- Phase I trials support the efficacy of personalized cancer vaccines.
Conclusions:
- Personalized neoantigen vaccines represent a significant advancement in cancer immunotherapy.
- Further research is needed to optimize vaccine design and application.
- Neoantigen-based vaccines are poised to revolutionize cancer treatment.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Personal Identity
The Effect of Aging on Tissues
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...

